We checked BAFFR expression in CD11c+Tbet+ B cells from patients with lupus to determine whether this could account for their increased reduction following belimumab-rituximab combination therapy paralleling the observations with IgA2 B cells. The gene discussed is TNFRSF13C; the disease is systemic lupus erythematosus.